Clinical Trial Update: An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

View source ↗

Summary

An observational study assessing the safety and efficacy of cetuximab in combination with platinum-based chemotherapy as first-line treatment for recurrent or m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Carcinoma, Squamous Cell | Status: TERMINATED